GSK agrees US drug price cuts and supply chain deal
GSK strikes a voluntary agreement with the US government to lower prescription medicine costs by up to 66% and bolster American drug supply chains. Read the full details.
GSK strikes a voluntary agreement with the US government to lower prescription medicine costs by up to 66% and bolster American drug supply chains. Read the full details.
Groundbreaking trial shows monthly tezepelumab injections allow severe asthma patients to reduce or stop steroid medication entirely. Discover this medical breakthrough.